In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio
Email Updates
Search
Fast Facts
Name Symbol Exchange
AlphaRx ALRX OTCBB
Shares Outstanding Financials Industry
92,371,192 as of October 2008 View Filings Technology & Medical
Transfer Agent Broker Fact Sheet Website
Fact Sheet http://www.AlphaRx.com
Recent Updates
AlphaRx RSS Feed
Industry Bulletin - Market Post Strong Weekly Gains
Nov 28, 08 02:30PM
Press Release - NEWS - AlphaRx and Gaia BioPharma Enter Into Feasibility and Option Agreement
Oct 22, 08 08:03AM
Press Release - NEWS - AlphaRx Appoints Leading Infectious Disease Specialist to Its Scientific Advisory Board
Sep 17, 08 08:01AM
Press Release - NEWS - AlphaRx Receives Conditional Approval to List on the TSX Venture Exchange
Aug 12, 08 08:00AM
Press Release - NEWS - Zysolin(TM) Improves Survival in Pivotal Animal Studies
Jun 26, 08 10:39AM
Top Rated Messages

Sorry, no rated messages found

See more top rated messages
Most Recent Messages
Re: Ask price
BundPataka
Jan 06, 09 03:06PM
Re: Ask price
markak15
Jan 05, 09 05:26PM
Re: Ask price
drummer
Jan 05, 09 12:01PM
Re: Ask price
markak15
Jan 02, 09 01:43PM
Re: Ask price
gimeen
Jan 02, 09 12:12PM
Go to Full Discussion Forum
Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote